An observational study in Stellate Ganglion, Facial Palsy and Pain Management, sponsored by Assiut University. Not yet recruiting. Per ClinicalTrials.gov, last updated 2024-12-19.
Sponsored by Assiut University · Observational
The goal of the present study is to verify the efficacy of stellate ganglion block (SGB) in the treatment of facial pain
81 studies on the registry are indexed under Facial Paralysis; 28 are open to participants now.
This study's planned enrollment of 34 is below the median of 80 across 21 observational studies indexed under Facial Paralysis.
Browse Facial Paralysis studies →Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
facial nerve palsy patients
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Drug: Stellate Ganglion Block
Stellate ganglion block is an injection of local anesthetic at the level of the neck to target the stellate ganglion, a sympathetic ganglion to interrupt abnormal autonomically-mediated pain in patients resistant to medical treatment
Primary outcome: Average motor conduction latency in six muscle of the face
Time frame: 6 month
Improved muscle tone
facial muscles start to regain their strength improvement of muscle tone.
Time frame: 6 months
No study locations are listed for this record.
This study is not yet recruiting, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.